Search Results - "Zygulska, Aneta Lidia"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Increased mean corpuscular volume as a predictor of response during bevacizumab treatment by Zygulska, Lidia, Krzemieniecki, Krzysztof

    Published in Archive of oncology (2012)
    “…Background: Remission during sunitinib (a multikinase inhibitor and antiangiogenic drug) treatment correlates with appearance of macrocytosis. There are some…”
    Get full text
    Journal Article
  2. 2

    Changes in plasma levels of cholecystokinin, neurotensin, VIP and PYY in gastric and colorectal cancer – Preliminary results by Zygulska, Aneta Lidia, Furgala, Agata, Kaszuba-Zwoińska, Jolanta, Krzemieniecki, Krzysztof, Gil, Krzysztof

    Published in Peptides (New York, N.Y. : 1980) (01-12-2019)
    “…•Alterations in peptide YY plasma concentration were observed in gastrointestinal cancer.•Plasma levels of cholecystokinin and vasoactive intestinal peptide…”
    Get full text
    Journal Article
  3. 3

    Macrocytosis during sunitinib treatment predicts progression-free survival in patients with metastatic renal cell carcinoma by Kucharz, Jakub, Giza, Agnieszka, Dumnicka, Paulina, Kuzniewski, Marek, Kusnierz-Cabala, Beata, Bryniarski, Pawel, Herman, Roma, Zygulska, Aneta Lidia, Krzemieniecki, Krzysztof

    “…Sunitinib, a multi-targeted receptor tyrosine kinase inhibitor, is a first-line treatment for metastatic renal cell carcinoma (mRCC) in patients in ‘low’ and…”
    Get full text
    Journal Article